Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levodopa only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa and levodopa only product in enteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benserazide and levodopa in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide and levodopa only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide 12.5 mg and levodopa 50 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide 12.5 mg and levodopa 50 mg oral capsule |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide 25 mg and levodopa 100 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benserazide 25 mg and levodopa 100 mg oral capsule |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa- and levodopa-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |